Evidence map›Paper›PMID 33927353›Full record

ReviewEye (London, England)2021

Recurring themes during cataract assessment and surgery.

Shruti Chandra, Sobha Sivaprasad, Paul G Ursell, Khayam Naderi, David O'Brart, Amar Alwitry, Zahra Ashena, Mayank A Nanavaty

Open access · bronzeAbstract readReview
In one paragraph

Review in Eye (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Shruti Chandra *NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-2634-9775
Sobha Sivaprasad *NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Paul G Ursell *Epsom & St Helier University Hospitals NHS Trust, Epsom, Surrey, UK.
Khayam Naderi *Department of Ophthalmology, Guy's and St. Thomas' NHS Foundation Trust, London, England.
David O'Brart *Department of Ophthalmology, Guy's and St. Thomas' NHS Foundation Trust, London, England.ORCID http://orcid.org/0000-0002-1065-3166
Amar Alwitry *Loughborough Hospital, Epinal Way, Loughborough, UK.
Zahra Ashena *Sussex Eye Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, UK.
Mayank A Nanavaty *Sussex Eye Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, UK. mayank.nanavaty@nhs.net.ORCID http://orcid.org/0000-0003-0667-3700
King's College London · GBMoorfields Eye Hospital NHS Foundation Trust · GBBrighton and Sussex Medical School · GBEpsom and St Helier University Hospitals NHS Trust · GBLoughborough Hospital · GBSussex Eye Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this review was to discuss frequently encountered themes such as cataract surgery in presence of age-related macular degeneration (AMD), dementia, Immediate Sequential Bilateral Cataract Surgery (ISBCS), discussing non-standard intraocular lens (IOL) options during consultation in the National Health Services (NHS) and the choice of the biometric formulae based on axial length. Individual groups of authors worked independently on each topic. We found that cataract surgery does improve visual acuity in AMD patients but the need for cataract surgery should be individualised. In patients with dementia, cataract surgery should be considered 'sooner rather than later' as progression may prevent individuals presenting for surgery. This should be planned after discussion of patients' best interests with any carers; multifocal IOLs are not proven to be the best option in these patients. ISBCS gives comparable outcomes to delayed sequential surgeries with a low risk of bilateral endophthalmitis and it can be cost-saving and efficient. Patients are entitled to know all suitable IOL options that can improve their quality of life. Deliberately withholding this information or pressuring patients to choose a non-standard IOL is inappropriate. However, one should be mindful of the not spending inappropriate amounts of time discussing these in the NHS setting which may affect care of other NHS patients. Evidence suggests Hoffer Q, Haigis, Hill-RBF and Kane formulae for shorter eyes; Barrett Universal II (BU II), Holladay II, Haigis and Kane formulae for longer eyes and BU II, Hill-RBF and Kane formulae for medium axial length eyes.

Indexed as

CataractLenses, IntraocularBiometryHumansLens Implantation, IntraocularNeoplasm Recurrence, LocalOptics and PhotonicsQuality of LifeRefraction, OcularRetrospective Studies

Identifiers

PMID33927353
PMCPMC8376990
OpenAlexW3158193752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.